Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Trial of Ferumoxytol for the Treatment of Iron Deficiency Anemia in Pediatric Subjects With Chronic Kidney Disease

This study has been terminated.
(Several factors contributed to significant challenges in enrollment and led the Sponsor to discontinue the AMAG-FER-CKD-251 study as designed.)
Information provided by (Responsible Party):
AMAG Pharmaceuticals, Inc. Identifier:
First received: June 28, 2010
Last updated: September 19, 2016
Last verified: September 2016
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: October 2015
  Primary Completion Date: October 2015 (Final data collection date for primary outcome measure)